BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6372394)

  • 1. Clinical equivalence of a new glucocorticoid, deflazacort and prednisone in rheumatoid arthritis and S.L.E. patients.
    Imbimbo B; Tuzi T; Porzio F; Schiavetti L
    Adv Exp Med Biol; 1984; 171():241-56. PubMed ID: 6372394
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term therapy with the new glucocorticosteroid deflazacort in rheumatoid arthritis. Double-blind controlled randomized 12-months study against prednisone.
    Eberhardt R; Krüger K; Reiter W; Gross W; Zwingers T
    Arzneimittelforschung; 1994 May; 44(5):642-7. PubMed ID: 8024639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of two glucocorticoid preparations (deflazacort and prednisone) in the treatment of immune-mediated diseases.
    Scudeletti M; Puppo F; Lanza L; Mantovani L; Bosco O; Iudice A; Imbimbo B; Indiveri F
    Eur J Clin Pharmacol; 1993; 45 Suppl 1():S29-34. PubMed ID: 8313931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind study of deflazacort and prednisone in patients with chronic inflammatory disorders.
    Gray RE; Doherty SM; Galloway J; Coulton L; de Broe M; Kanis JA
    Arthritis Rheum; 1991 Mar; 34(3):287-95. PubMed ID: 2003854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of low doses of deflazacort vs prednisone on bone mineral content in premenopausal rheumatoid arthritis.
    Messina OD; Barreira JC; Zanchetta JR; Maldonado-Cocco JA; Bogado CE; Sebastián ON; Flores D; Riopedre AM; Redondo G; Lázaro A
    J Rheumatol; 1992 Oct; 19(10):1520-6. PubMed ID: 1464862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized, double-blind trial of deflazacort versus prednisone in juvenile chronic (or rheumatoid) arthritis: a relatively bone-sparing effect of deflazacort.
    Loftus J; Allen R; Hesp R; David J; Reid DM; Wright DJ; Green JR; Reeve J; Ansell BM; Woo PM
    Pediatrics; 1991 Sep; 88(3):428-36. PubMed ID: 1881719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex hormones and bone metabolism in postmenopausal rheumatoid arthritis treated with two different glucocorticoids.
    Montecucco C; Caporali R; Caprotti P; Caprotti M; Notario A
    J Rheumatol; 1992 Dec; 19(12):1895-900. PubMed ID: 1294736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of the reserve of the adrenocortical hypophysis after long-term corticotherapy].
    Witoszyński S
    Endokrynol Pol; 1968; 19(1):39-46. PubMed ID: 4875926
    [No Abstract]   [Full Text] [Related]  

  • 9. Deflazacort. A review of its pharmacological properties and therapeutic efficacy.
    Markham A; Bryson HM
    Drugs; 1995 Aug; 50(2):317-33. PubMed ID: 8521761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute changes in urinary radiocalcium following glucocorticoids administration in man.
    Gennari C; Scala C; Imbimbo B; Bernini M; Montagnani M; Nardi P; Fusi L; Avioli LV
    Adv Exp Med Biol; 1984; 171():407-15. PubMed ID: 6372402
    [No Abstract]   [Full Text] [Related]  

  • 11. Comment on the study of deflazacort versus prednisone in the treatment of chronic inflammatory disorders.
    Messina OD; Barreira JC
    Arthritis Rheum; 1992 Jul; 35(7):841-2. PubMed ID: 1622425
    [No Abstract]   [Full Text] [Related]  

  • 12. Assessment of the quality of life in kidney transplant patients: a randomized, double-blind comparison of Deflazacort and prednisone.
    Alvarez-Amador L; Alvarado-Vega AG; Zúñiga-Armendáriz V; Zaragoza RM; Diliz HS; Arce-Salinas CA
    Transplant Proc; 1996 Dec; 28(6):3391-3. PubMed ID: 8962324
    [No Abstract]   [Full Text] [Related]  

  • 13. Establishment of the relative antiinflammatory potency of deflazacort and prednisone in polymyalgia rheumatica.
    Lund B; Egsmose C; Jørgensen S; Krogsgaard MR
    Calcif Tissue Int; 1987 Dec; 41(6):316-20. PubMed ID: 3124940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deflazacort in thrombocytopenia: a comparison with prednisone.
    Mazzucconi MG; Malagnino F; De Laurentis C; Criscuolo D
    Int J Clin Pharmacol Ther Toxicol; 1980 Dec; 18(12):538-42. PubMed ID: 7194867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermittent prednisone adequate for arthritis and lupus?
    Sheon RP
    Postgrad Med; 1999 Aug; 106(2):164, 167. PubMed ID: 10456048
    [No Abstract]   [Full Text] [Related]  

  • 16. [Research on the effects of azathioprine (Imuran) in rheumatoid arthritis and lupic diseases].
    Bruckner I; Stroescu O; Stroescu V; Gheorghiu M; Suţeanu S; Ghelerter L; Grozea P; Bârnaş M
    Med Interna (Bucur); 1969 May; 21(5):583-92. PubMed ID: 5344550
    [No Abstract]   [Full Text] [Related]  

  • 17. Low dose prednisone therapy in rheumatoid arthritis: a double blind study.
    Harris ED; Emkey RD; Nichols JE; Newberg A
    J Rheumatol; 1983 Oct; 10(5):713-21. PubMed ID: 6358491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rheumatoid arthritis followed by systemic lupus erythematosus.
    Ansell BM
    Proc R Soc Med; 1975 Sep; 68(9):596-7. PubMed ID: 1197347
    [No Abstract]   [Full Text] [Related]  

  • 19. A randomized study comparing deflazacort and prednisone in heart transplant patients.
    Arizón JM; Anguita M; Vallés F; López-Rubio F; López-Granados A; Casares J; Segura J; Mesa D; Muñoz I; Alados P
    J Heart Lung Transplant; 1993; 12(5):864-8. PubMed ID: 8241229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of prednisone and deflazacort on vertebral bone mass.
    Gennari C; Imbimbo B
    Calcif Tissue Int; 1985 Dec; 37(6):592-3. PubMed ID: 3937579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.